Analysis of factors for Bio-free remission due to the Tight control by Remicade in rheumatoid arthritis patients. Birdie study
Phase 4
Recruiting
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-UMIN000009435
- Lead Sponsor
- Osaka City University Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who already achieved remission after stopping infliximab
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method